Published in J Pediatr on June 01, 1998
B-cell responses to vaccination at the extremes of age. Nat Rev Immunol (2009) 2.50
Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol (2000) 2.40
Role of antibodies in immunity to Bordetella infections. Infect Immun (2003) 1.71
Modeling systems-level regulation of host immune responses. PLoS Comput Biol (2007) 1.56
Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect Immun (1999) 1.25
Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin Exp Immunol (2000) 1.12
Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice. J Clin Invest (2010) 1.05
Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory. Infect Immun (2006) 1.03
Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS One (2012) 1.00
Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection. Infect Immun (2001) 0.93
Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin. Infect Immun (2008) 0.89
Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination. Clin Vaccine Immunol (2013) 0.88
Monocyte-derived interleukin-10 depresses the Bordetella pertussis- specific gamma interferon response in vaccinated infants. Clin Vaccine Immunol (2009) 0.86
Unraveling the challenges of pertussis. Proc Natl Acad Sci U S A (2013) 0.85
Licensed pertussis vaccines in the United States. History and current state. Hum Vaccin Immunother (2014) 0.84
Sensitivity and specificity of single IgA and IgG antibody concentrations for early diagnosis of pertussis in adults: an evaluation for outbreak management in public health practice. BMC Infect Dis (2007) 0.82
T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice. Clin Diagn Lab Immunol (2003) 0.81
Waning and aging of cellular immunity to Bordetella pertussis. Pathog Dis (2015) 0.81
An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice. J Virol (2014) 0.80
Identification of pertussis-specific effector memory T cells in preschool children. Clin Vaccine Immunol (2015) 0.77
The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections. PLoS One (2016) 0.76
A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model. Vaccine (2014) 0.76
The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis. F1000Res (2017) 0.75
Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model. Vaccine (2017) 0.75
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med (1996) 4.86
Morbidity and mortality associated with the July 1980 heat wave in St Louis and Kansas City, Mo. JAMA (1982) 3.69
Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect (2007) 3.27
Outbreak of Salmonella napoli infection caused by contaminated chocolate bars. Lancet (1983) 2.82
Risk factors for delayed immunization in a random sample of 1163 children from Oregon and Washington. Pediatrics (1993) 2.74
"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem (2006) 2.58
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA (1987) 2.28
Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 2.25
An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes. N Engl J Med (2000) 2.21
Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J (1987) 2.13
Continuing measles transmission in students despite school-based outbreak control program. Am J Epidemiol (1985) 2.09
The Vaccine Adverse Event Reporting System (VAERS). Vaccine (1994) 2.02
The health and economic burden of cigarette smoking in Georgia in 1985. J Med Assoc Ga (1989) 1.94
A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect (2003) 1.94
Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill (2010) 1.90
Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study. JAMA (1994) 1.71
Health impact of measles vaccination in the United States. Pediatrics (1985) 1.71
Practical experiences in obtaining informed consent for a vaccine trial in rural Africa. N Engl J Med (1997) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill (2008) 1.63
Efficacy of whole-cell pertussis vaccine in preschool children in the United States. JAMA (1992) 1.60
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis (1992) 1.55
An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol (1989) 1.53
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Computerized tomography of the abdomen and pelvis with peritoneal administration of soluble contrast (IPC-CT) in detection of residual disease for patients with ovarian cancer. Gynecol Oncol (1994) 1.42
Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis (1998) 1.38
A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37
A foodborne outbreak of gastroenteritis involving Listeria monocytogenes. Epidemiol Infect (1996) 1.37
Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. J Antimicrob Chemother (2001) 1.30
Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization. Infect Immun (1990) 1.29
Effects of Clostridium difficile toxins A and B on cytoskeleton organization in HEp-2 cells: a comparative morphological study. Toxicon (1989) 1.27
Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect Immun (1999) 1.25
Characterization of surface layer proteins from different Clostridium difficile clinical isolates. Microb Pathog (2000) 1.23
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics (2001) 1.23
Pertussis epidemic in Oklahoma. Difficulties in preventing transmission. Am J Dis Child (1986) 1.23
Molecular and genomic analysis of genes encoding surface-anchored proteins from Clostridium difficile. Infect Immun (2001) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill (2009) 1.18
Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. Arch Pediatr Adolesc Med (1997) 1.17
Enteropathogens associated with childhood diarrhea in Italy. The Italian Study Group on Gastrointestinal Infections. Pediatr Infect Dis J (1996) 1.15
Characterization of non-type B Haemophilus influenzae strains isolated from patients with invasive disease. The HI Study Group. J Clin Microbiol (2000) 1.14
Surface blebbing and cytoskeletal changes induced in vitro by toxin B from Clostridium difficile: an immunochemical and ultrastructural study. Exp Mol Pathol (1990) 1.13
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Risk behaviors for HIV-1 infection in Italian drug users: report from a multicenter study. First Drug User Multicenter Study Group. J Acquir Immune Defic Syndr (1989) 1.09
Determinants of acquiring hepatitis A virus disease in a large Italian region in endemic and epidemic periods. J Viral Hepat (2005) 1.09
Epidemiological surveillance of West Nile neuroinvasive diseases in Italy, 2008 to 2011. Euro Surveill (2012) 1.09
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Epidemiological use of drug prescriptions as markers of disease frequency: an Italian experience. J Clin Epidemiol (1991) 1.08
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Epidemiology of tetanus in Italy in years 1971-2000. Euro Surveill (2002) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
The seroepidemiology of measles in Western Europe. Epidemiol Infect (2001) 1.04
Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04
Antibiotic susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Italy, 1997-1999. Clin Infect Dis (2000) 1.04
Measles seroconfirmation using dried capillary blood specimens in filter paper. Pediatr Infect Dis (1984) 1.03
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. Maturitas (2005) 1.03
Measles resurges in Italy: preliminary data from September 2007 to May 2008. Euro Surveill (2008) 1.02
Response to the 2009 influenza A(H1N1) pandemic in Italy. Euro Surveill (2010) 1.01
Assessment of varicella underreporting in Italy. Epidemiol Infect (2002) 1.01
A fatal postpartum Clostridium sordellii associated toxic shock syndrome. J Clin Pathol (1997) 1.00
Measles elimination in Italy: projected impact of the National Elimination Plan. Epidemiol Infect (2005) 1.00
Epidemiology of measles, mumps and rubella in Italy. Epidemiol Infect (2002) 1.00
Characterisation of Neisseria meningitidis C strains causing two clusters in the north of Italy in 2007 and 2008. Euro Surveill (2009) 1.00
All classifications not built on pathogenesis become inadequate sooner or later. Diabetologia (2011) 0.99
Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99
Prevalence of HNPCC in a series of consecutive patients on the first endoscopic diagnosis of colorectal cancer: a multicenter study. The Italian Collaborative Group. Endoscopy (1999) 0.98
Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98
Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J Infect Dis (2000) 0.98
Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill (2008) 0.98
Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97
Prevalence of Toxoplasma gondii antibodies among children and teenagers in Italy. Microbiologica (1991) 0.97
Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group. Vaccine (1998) 0.97
Recurrence of Pelecypod-associated cholera in Sardinia. Lancet (1980) 0.96
Enhanced epidemiological surveillance of influenza A(H1N1)v in Italy. Euro Surveill (2009) 0.96
Cluster of invasive Neisseria meningitidis infections on a cruise ship, Italy, October 2012. Euro Surveill (2012) 0.95
Molecular typing and long-term comparison of clostridium difficile strains by pulsed-field gel electrophoresis and PCR-ribotyping. J Med Microbiol (2001) 0.95
Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2013) 0.95
Search for dark matter and large extra dimensions in pp collisions yielding a photon and missing transverse energy. Phys Rev Lett (2012) 0.95
Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience. Pediatr Infect Dis J (1992) 0.95
The seroepidemiology of rubella in western Europe. Epidemiol Infect (2000) 0.93
Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection. Infect Immun (2001) 0.93
Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy. Infection (1991) 0.93
Role of Clostridium difficile in childhood diarrhea. Pediatr Infect Dis J (1995) 0.92